Barriers to publishing early phase clinical trials: the oncologists' perspective.

ABSTRACT:

Introduction

Findings from early phase studies are not always placed in the public domain. This study aims to explore why many early phase clinical oncology studies are not published, as well as identify the potential barriers investigators encountered in the publication process.

Methods

Semi-structured interviews were conducted among investigators with experience in early phase clinical oncology studies. Interviews were analyzed using reflexive thematic analysis.

Results

Twenty-one investigators were interviewed. The majority worked in Europe (n = 13), while other investigators were based in North America (n = 4), Asia (n = 2) or Oceania (n = 2). We identified three reasons why investigators believed publishing early phase clinical trial results was important: (1) th

SUBMITTER: Lucassen MJJ 

PROVIDER: S-EPMC12019228 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature